About: http://webisa.webdatacommons.org/148672279

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Celgene rose 5.8% after the company's subsidiary in Sweden said a Phase 3 trial of its treatment for pancreatic cancer met its primary goal, which will lead the company to submit registration papers in the U.S, Europe and other markets.
http://www.w3.org/ns/prov#wasQuotedFrom	advfn.com